MedTrace Logo

Ethyl Glucuronide in Urine Samples of Pregnant Women Within the HUS ja PHHYKY Area

NCT04571463 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 505

Last updated 2022-11-28

No results posted yet for this study

Summary

In order to find how many women continue using alcohol during their pregnancies the plan is to anonymously test routine urine samples collected during pregnancies for ethylglucuronide (ETG), a metabolite of ethanol that is detectable in urine up to several days after alcohol consumptions. Altogether 600 samples are taken in the prenatal care units and the prenatal care units dedicated for the alcohol and drug abusing mothers both in the Helsinki and Lahti areas. Test results are used to estimate and compare the prevalence of severe maternal drinking in the different populations.

Conditions

  • Fetal Alcohol Spectrum Disorders

Sponsors & Collaborators

  • Finnish Pediatric Neurology Association

    collaborator UNKNOWN

  • Finnish Foundation for Alcohol Studies

    collaborator OTHER

  • Päijänne Tavastia Central Hospital

    collaborator OTHER

  • Helsinki University Central Hospital

    collaborator OTHER

  • Seinajoki Central Hospital

    collaborator OTHER

  • Hanna Kahila

    lead OTHER

Principal Investigators

  • Hanna Kahila, MD · HUCS

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-07-30
Completion
2021-07-30

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04571463 on ClinicalTrials.gov